Emerging studies suggest Retatrutide , a dual agonist targeting both GLP-1 and another hormone, could provide a notable step forward for body loss . Preliminary patient trials have demonstrated https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026